Abstract
The main objective of this study was to assess the effects of the generic drug scandal on pharmacists' product choice criteria. A study on attributcs that determine pharmacists' choice of multisource products conductcd before the scandal was repeated to examine how pharmacists' perceptions changed after the scandal. Myers and Alpert's determinance model was employed to identify determinant attributes in pharmacists' drug product choice decisions. In the postscandal study, 24 attributes were identified as determinant, including 23 that were identified as determinant in the prescandal study. Perceptions on two attributes changed between the prescandal 'and postscandal periods. However, perceptions on 41 other attributes remained the same, indicating the relative stability of the determinant attributes.